Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „zonisamide“
Suchtreffer
Begriffe & Kennungen
Zonisamide Viatris (previously Zonisamide Mylan) · 4.8 · 12 System Organ Very Common Uncommon Very Rare Class (MedDRA Common terminology) Eye disorders Diplopia Angle
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · 13 zonisamide with carbamazepine prolonged release
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · 14 Review of post-marketing data suggests that patients aged 65 years or older report a higher frequency than
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Additional information on special populations
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Elderly A pooled analysis of safety data on 95 elderly subjects has shown a relatively higher reporting freque
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · In addition there have been isolated cases of Sudden Unexplained Death in Epilepsy Patients (SUDEP) receiving
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · It should be noted that zonisamide is a benzisoxazole derivative, which contains a sulfonamide group. Serious
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Nervous system Ataxia Bradyphrenia Convulsion Amnesia disorders Dizziness Disturbance in Coma Memory attention
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Paediatric population The adverse event profile of zonisamide in paediatric patients aged 6 to 17 years in pla
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Summary of the safety profile Zonisamide has been administered to over 1,200 patients in clinical studies, mor
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · System Organ Class Very Common Common Uncommon (MedDRA terminology†) Infections and Urinary tract infection in
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · System Organ Very Common Uncommon Very Rare Class (MedDRA Common terminology) Infections and Pneumonia infesta
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Table 4. Adverse reactions associated with zonisamide obtained from adjunctive use clinical studies and post-m
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Table 5. Adverse reactions in a randomised, controlled monotherapy trial comparing
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · Tabulated list of adverse reactions Adverse reactions associated with zonisamide obtained from clinical studie
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · The most common adverse reactions in controlled adjunctive-therapy studies were somnolence, dizziness and anor
Eintrag öffnenZonisamide Viatris (previously Zonisamide Mylan) · 4.8 · very common ≥ 1/10 common ≥ 1/100 to < 1/10 uncommon ≥ 1/1,000 to < 1/100 rare ≥ 1/10,000 to < 1/1,000 very ra
Eintrag öffnenzonisamide
Eintrag öffnen